WealthTrust Axiom’s Trevi Therapeutics TRVI Stock Holding History

WealthTrust Axiom’s Portfolio TRVI Stock Details TRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$734K	Hold	61,500	–	–	0.18%	108
2025 Q4	$770K	Hold	61,500	–	–	0.2%	102
2025 Q3	$563K	Hold	61,500	–	–	0.15%	134
2025 Q2	$336K	Sell	61,500 -2,000	-3%	-$12.4K	0.1%	172
2025 Q1	$399K	Sell	63,500 -2,000	-3%	-$9.54K	0.12%	155
2024 Q4	$270K	Buy	65,500 +2,000	+3%	+$6.4K	0.08%	193
2024 Q3	$212K	Hold	63,500	–	–	0.06%	230
2024 Q2	$189K	Hold	63,500	–	–	0.06%	226
2024 Q1	$219K	Hold	63,500	–	–	0.07%	219
2023 Q4	$85.1K	Sell	63,500 -30,000	-32%	-$45.4K	0.03%	236
2023 Q3	$204K	Hold	93,500	–	–	0.07%	208
2023 Q2	$223K	Hold	93,500	–	–	0.07%	211
2023 Q1	$173K	Hold	93,500	–	–	0.06%	219
2022 Q4	$180K	Hold	93,500	–	–	0.06%	212
2022 Q3	$143K	Hold	93,500	–	–	0.05%	216
2022 Q2	$262K	Sell	93,500 -5,000	-5%	-$12.3K	0.09%	179
2022 Q1	$216K	Buy	98,500 +70,000	+246%	+$72.5K	0.07%	217
2021 Q4	$22K	Sell	28,500 -8,000	-22%	-$8.4K	0.01%	259
2021 Q3	$51K	Sell	36,500 -3,000	-8%	-$5.31K	0.02%	246
2021 Q2	$88K	Buy	39,500 +1,000	+3%	+$2.25K	0.03%	249
2021 Q1	$104K	Buy	38,500 +27,000	+235%	+$79.1K	0.04%	232
2020 Q4	$27K	Buy	+11,500	New	+$37.2K	0.01%	236

Other funds holding TRVI

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return